PHARMACYTE BIOTECH, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $6.7M | $2.2M |
| FY2022 | — | $89.9M | $85.4M |
| FY2023 | — | $72.7M | $68.0M |
| FY2024 | — | $27.6M | $50.2M |
| FY2025 | — | $51.9M | $15.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $6.7M | $2.2M |
| FY2022 | — | $89.9M | $85.4M |
| FY2023 | — | $72.7M | $68.0M |
| FY2024 | — | $27.6M | $50.2M |
| FY2025 | — | $51.9M | $15.2M |